| Line 18: |
Line 18: |
| | |- | | |- |
| | | 34 || CXR | | | 34 || CXR |
| | + | |- |
| | + | | 35 || CT head |
| | |} | | |} |
| | | | |
| Line 25: |
Line 27: |
| | |- | | |- |
| | | 28 || Antiemetic | | | 28 || Antiemetic |
| | + | |- |
| | + | | 35 || Thiamine |
| | + | |- |
| | + | | 35 || Folate |
| | + | |- |
| | + | | 35 || Magnesium sulfate |
| | + | |- |
| | + | | 35 || Lorazepam |
| | |} | | |} |
| | | | |
| Line 37: |
Line 47: |
| | | 28 || Treat partner | | | 28 || Treat partner |
| | |- | | |- |
| − | | 34 || Medication compliance | + | | 34 || Med compliance |
| | + | |- |
| | + | | 35 || Naltrexone |
| | + | |- |
| | + | | 35 || Consult social services |
| | + | |- |
| | + | | 35 || Med compliance |
| | |} | | |} |